DOCGO Inc. SHAREHOLDERS: Contact Robbins LLP for Information Regarding the DocGo Inc. (DCGO) Securities Fraud Class Action
November 13, 2023 18:52 ET
|
Robbins LLP
DocGo Inc. (DCGO) Misled Investors Regarding the Efficacy of its Mobile Health and Medical Transportation Services
OTLK Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in the Outlook Therapeutics, Inc. Class Action
November 13, 2023 18:08 ET
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
SCYX Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Scynexis, Inc. (SCYX) Class Action
November 13, 2023 17:01 ET
|
Robbins LLP
Scynexis, Inc. (SCYX) Misled Investors Regarding its Quality Control Measures
FARFETCH LIMITED SHAREHOLDERS: Contact Robbins LLP for Information Regarding the Farfetch Limited (FTCH) Securities Class Action
November 13, 2023 17:01 ET
|
Robbins LLP
Farfetch Limited (FTCH) Misled Investors Regarding its Business Prospects
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against FMC Corporation (FMC)
November 13, 2023 16:35 ET
|
Robbins LLP
FMC Corporation (FMC) Misled Investors Regarding Patent Protection for its Flagship Products
PURECYCLE STOCK ALERT: Don't Miss the Lead Plaintiff Deadline in the PCT Class Action, Contact Robbins LLP Today
November 09, 2023 19:09 ET
|
Robbins LLP
PureCycle Technologies, Inc. (PCT) Failed to Inform Investors its FlatIron Facility Experienced a Power Outage
ADBE INVESTOR ALERT: Contact Robbins LLP for Information about Your Rights Against Adobe Inc.
November 09, 2023 18:28 ET
|
Robbins LLP
Adobe Inc. (ADBE) Misled Investors Regarding its Competitor Figma
AHCO INVESTOR ALERT: Contact Robbins LLP for Information about Your Rights Against AdaptHealth Corp.
November 09, 2023 18:06 ET
|
Robbins LLP
AdaptHealth Corp. (AHCO) Misrepresented the Success and Growth of its Diabetes Segment
DMTK STOCK NEWS: Shareholders With Large Losses Should Contact Robbins LLP for Information About Their Rights Against DermTech, Inc.
November 08, 2023 15:34 ET
|
Robbins LLP
DermTech, Inc. (DMTK) Misled Investors Regarding its Business Prospects
Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc.
November 08, 2023 15:32 ET
|
Robbins LLP
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn